Readers weigh in on health research topics

June 11’s First Opinion by Elizabeth Selvin represents common misunderstandings of the economics of scientific publishing today. We would like to clarify some points to further the conversation.
False: Not paying an article-processing charge (APC) to be published means being published without one was “free.”
Fact: There is a cost either way, and hybrid (subscription + free articles) journals like Nature Medicine need to split the difference.
Related: Medicare Advantage ratings face new changes
False: The publisher is to blame for the “new” cost.
Fact: If the cost of open-access fees is a financial hardship, there is a global shopping mall at your fingertips. Citations and press coverage for a paper in Nature Medicine pay dividends in academic credibility and further funding opportunities. Everyone knows that.
False: The cost was unavoidable.
Related: Why Health Care is Essential for Success: A Foundation for Thriving
Fact: The return on investment on a publication fee that is a percentage of an R01 grant is relative.
False: PubMed Central sans embargo is the way to go.
Fact: Congress allocates tax dollars for research grants. Reports of this research may turn into scientific papers. Publishers independently assess these reports and take financial risks for their authors. PubMed Central is a secondary U.S. taxpayer-funded platform created to support “public access” compliance. Like any tech platform, it is expensive to run and maintain. It hosts content from authors and publishers across the globe while U.S. taxpayers foot the bill.
Related: Exploring the Multifaceted Benefits of Healthy Food
We understand Selvin’s point of view. Blaming independent commercial publishers for trying to run their businesses while an untrustworthy U.S. government changes policies on a whim, however, is just the tip of a messy iceberg that op-eds like hers make messier. Comparing the “costs” of publishing in Nature Medicine to what she has gleaned from her time as a part-time editor for an American Diabetes Association journal is comparing apples and oranges. It is of no help to her fellow U.S. scientific colleagues who are getting squeezed.
Selvin is right that publicly funded research should be widely accessible to support knowledge and discovery, a goal Springer Nature shares. However, the piece misses important distinctions, particularly around article processing charges (APCs). Publishing is both resource intensive and high value. Under a subscription model, institutions and libraries that subscribe to journals cover the cost. Publishing open access without embargo periods — which NIH policy requires — shifts those costs to APCs, which are typically covered by research funds. Our APCs are transparent and reflect the costs associated with publishing high-quality trusted research. APCs support editorial evaluation, independent review, formatting, and distribution, and ensure continuous access to publications. They also allow for investment in research integrity infrastructure, including advanced detection of fraudulent submissions — essential to ensuring published science can be trusted.
Springer Nature’s average APC is $2,500. For high-impact, selective journals like those in the Nature portfolio, costs are higher due to the time, expertise, and investment required. These journals receive a very high number of submissions, meaning specialist teams assess many more papers than are ultimately published, resulting in higher costs per article. Our authors retain copyright in their work. We are granted a license to publish by the author so we can ensure their work reaches the widest number of people and has the greatest impact. Licensing terms help protect authors’ work from reuse in ways that are not transparent or aligned with their intentions. Access to trusted research is central to scientific and societal progress. We are committed to partnering with researchers and the federal government to support this shared goal.